FTC cows Sanofi into giving up on Maze licensing deal
Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.
Jeffrey Sonnenfeld Lina Khan Lumizyme Myozyme Nate Soderstrom Justice Department Drug Administration
Source: mmm-online.com